Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Roche Holding AG
  6. News
  7. Most relevant
    ROG   CH0012032048

ROCHE HOLDING AG

(ROG)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about ROCHE HOLDING AG
11/26Chugai Pharmaceutical Co. - Anti Cancer Agent Herceptin Approved for Additional Indicat..
AQ
11/26Roche Shareholders Approve Deal to Buy Back Novartis' Stake in Swiss Drugmaker
MT
11/26Roche shareholders approve deal to buy Novartis's $20.7 billion stake
RE
11/26Roche Shareholders OK $21 Billion Repurchase Deal With Novartis
MT
11/26Roche shareholders approve deal to buy Novartis's $20.7 billion stake
RE
11/26Roche Extraordinary General Meeting 2021
AQ
11/24ROCHE HOLDINGS AG : UBS sticks Neutral
MD
11/24ROCHE HOLDINGS AG : Buy rating from Deutsche Bank
MD
11/23Beijing IP Court To Hear China's First Case Of Patent Linkage
AQ
11/23Genentech to Present New Pivotal Data at ASH 2021 From Broad and Comprehensive Portfoli..
BU
11/23Roche to present new pivotal data at ASH 2021 from broad and comprehensive portfolio, c..
AQ
11/23Roche to Present New Pivotal Data at ASH 2021 from Broad and Comprehensive Portfolio, C..
CI
11/22NICE draft guidance recommends new treatment for spinal muscular atrophy as part of a m..
AQ
11/19EQT, BioNTech investor consider bid for Novartis arm Sandoz -report
RE
11/19Roche Gets European Commission's Marketing Authorization for Lung Cancer Drug Gavreto
MT
11/19European Commission approves Roche's Gavreto (pralsetinib) for the treatment of adults ..
AQ
11/19European Commission Approves Roche?s Gavreto (Pralsetinib) for the Treatment of Adults ..
CI
11/18Shell, Nedbank, FedEx, AWS, Roche, AGRA, City of Johannesburg and PayFast Partner for A..
AQ
11/18Novartis Said Considering Takeover in Biotech Sector
MT
11/18Roche Launches New PCR Molecular Testing Instrument
MT
11/18Roche launches cobas 5800, a new molecular diagnostics system to expand access to testi..
AQ
11/18Roche Announces the Launch of the Cobas? 5800 System
CI
11/17GLOBAL MARKETS LIVE : Tesla, Experian, Roche, Activision, Amazon...
AX
11/17Atea Pharma Shares Drop 16% After Collaboration With Roche Terminated
DJ
11/16Roche, Atea Pharmaceuticals Cancel COVID-19 Therapy Development Partnership
MT
11/16Roche walks away from Atea partnership to develop COVID-19 pill
RE
11/16Atea Pharma says deal to develop COVID-19 pill with Roche terminated
RE
11/16Chugai Continuously Selected in the 'DJSI World,' a Global ESG Investment Index
AQ
11/16ROCHE : Invitation to Roche's virtual event on key hematology data presented at ASH 2021
PU
11/15ROCHE : Invitation to Roche's virtual analyst event during ESMO IO
PU
11/15Roche Selected Among Dow Jones' Top Sustainable Healthcare Companies
MT
11/15Roche ranked as one of the top three most sustainable healthcare companies in the Dow J..
AQ
11/12REFILE-UPDATE 4-Biden will nominate industry-friendly Califf to lead U.S. FDA
RE
11/12European Commission Grants Marketing Authorization For Roche's COVID-19 Antibody Cockta..
MT
11/12Ronapreve approved by European Commission to treat non-hospitalised COVID-19 patients a..
AQ
11/12Investing in stability
11/12EC Formally Authorises COVID-19 Drugs From Regeneron-Roche, Celltrion
RE
11/12GSK-Vir COVID-19 antibody works as shot in the arm as well as infusion
RE
11/11EU Drug Regulator Backs COVID-19 Therapy from South Korea's Celltrion
MT
11/11Roche, Regeneron's COVID-19 Antibody Cocktail Gets European Medicines Agency's Recommen..
MT
11/11Regeneron Gets CHMP Backing for Covid-19 Cocktail
DJ
11/11European Medicines Agency Recommends Ronapreve, Regkirona Covid-19 Treatments for Appro..
DJ
11/11CHMP recommends EU approval of Ronapreve to treat non-hospitalised COVID-19 patients an..
AQ
11/11Roche Holding Ag Announces That the European Medicines Agency?S Committee for Medicinal..
CI
11/11AC Immune Announces Late-Breaker Presentation by Genentech at CTAD on Phase 2 Lauriet S..
AQ
11/11REMINDER : Invitation to Roche's Virtual Event "Digitalization along the value chain"
PU
11/11ROCHE HOLDINGS AG : Goldman Sachs maintains a Buy rating
MD
11/10Roche To Price Alzheimer's Drug Below Rival Biogen's Aduhelm, Executive Says
MT
11/10Roche executive says Alzheimer's drug price will be competitive
RE
11/09EU Poised To Approve Two COVID-19 Antibody Drugs
MT
11/09Amid spike in cases, EU to shortly approve first COVID antibody drugs - sources
RE
11/09Amid spike in cases, EU to shortly approve first COVID antibody drugs - sources
RE
11/09ROCHE HOLDINGS AG : UBS reiterates its Neutral rating
MD
11/08Henlius Biotech Completes Phase 1 Clinical Trial of Breast Cancer Drug Biosimilar
MT
11/08GLOBAL MARKETS LIVE : Qiagen, Alcon, Boeing, Berkshire Hathaway...
11/08Oncolytics Biotech Reports 2021 Third Quarter Development Highlights and Financial Resu..
AQ
11/08First Patient Dosed in SELECT-AML-1 Trial of Tamibarotene and in Dose Confirmation Stud..
AQ
11/08Chugai Pharmaceutical - The Antibody Cocktail, Ronapreve Approved for Additional Indica..
AQ
11/08New Phase 3 analyses show that a single dose of REGEN-COV (casirivimab and imdevimab) p..
PU
11/08Moody's Affirms Swiss Drugmaker Roche's Rating Amid Novartis Deal
MT
11/08Novartis Expects $20.8 Billion Proceeds From Roche Stake Disposal
MT
11/07Roche's COVID-19 Antibody Gets Japanese Regulatory Nod For Additional Indication
MT
11/06S.Korea to purchase 70,000 courses of new Pfizer COVID-19 pill
RE
11/06Roche chairman sees greater flexibility after Novartis deal - paper
RE
11/05Ronapreve Approved for Additional Indication as a Preventive Treatment of Symptomatic C..
PU
11/05ROCHE HOLDINGS AG : Berenberg reiterates its Neutral rating
MD
11/05Swiss Takeover Board Exempts Roche Controlling Family From Making Offer to Shareholders
MT
11/05Roche controlling family won't have to make offer after Novartis deal
RE
11/05Berenberg Lifts Price Target on Roche, Maintains Hold Recommendation
MT
11/05Roche says controlling family won't have to make offer to other shareholders
RE
11/05Publication pursuant to Art. 61 para. 3 and 4 of the Ordinance of the Swiss Takeover Bo..
PU
11/04Health Care Down As Moderna Weighs -- Health Care Roundup
DJ
11/04GLOBAL MARKETS LIVE : Electronic Arts, Credit Suisse, Novartis, Merck, Tesla...
11/04ROCHE HOLDINGS AG : Goldman Sachs maintains a Buy rating
MD
11/04MarketScreener's World Press Review - November 4, 2021
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on ROCHE HOLDING AG